<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04578418</url>
  </required_header>
  <id_info>
    <org_study_id>H-16019857</org_study_id>
    <nct_id>NCT04578418</nct_id>
  </id_info>
  <brief_title>Effect of Collagen Supplementation on Tendinopathy</brief_title>
  <official_title>Effect of Collagen Supplementation on Tendinopathy in Elite Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Team Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tendon injuries represent a significant problem in elite athletes. Therefore, prevention and&#xD;
      effective treatment of tendon overload injury/tendinopathy is important. Among different&#xD;
      treatment options, heavy-slow loading based rehabilitation is considered among the most&#xD;
      efficient treatments in athletes. In this study, we will investigate if supplementation with&#xD;
      hydrolyzed collagen in combination with a heavy-slow loading based 12 weeks rehabilitation&#xD;
      regime can improve treatment of tendon overload injury/tendinopathy. The investigators will&#xD;
      examine elite athletes with overload injury/tendinopathy with regards to symptoms (pain,&#xD;
      function), tendon morphology (ultrasonography), and vascularization (Doppler US). The&#xD;
      investigators hypothesize that collagen supplementation can have an improving effect on&#xD;
      tendon pain and function. Thus, the investigation will show if a rehabilitation regime of&#xD;
      collagen supplementation combined with heavy-slow mechanical loading can improve tendon&#xD;
      healing compared to mechanical loading alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized placebo-controlled intervention study with follow-up after one month&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal tendon pain during the past week at preferred sporting activity</measure>
    <time_frame>Baseline-12 weeks</time_frame>
    <description>Change from baseline - 12 weeks using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximal tendon pain during the past week at preferred sporting activity</measure>
    <time_frame>Baseline, 6 weeks + 6 month follow-up</time_frame>
    <description>Change from baseline - 6 weeks + 1 month follow-up using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported activity level of sporting activities (hours/week)</measure>
    <time_frame>Baseline, 6 and 12 weeks + 6 month follow-up</time_frame>
    <description>Participants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single-leg decline squat (SLDS) test</measure>
    <time_frame>Baseline - 12 weeks</time_frame>
    <description>A reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Jump test</measure>
    <time_frame>Baseline - 12 weeks</time_frame>
    <description>A reliable Achilles/Plantaris tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment satisfaction</measure>
    <time_frame>12 weeks</time_frame>
    <description>Participants will be asked after the intervention period whether they were satisfied or not with the treatment (dichotom : Yes vs. No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collagen supplement</measure>
    <time_frame>Baseline - 12 weeks + 6 month follow-up</time_frame>
    <description>Participants will be asked on a weekly basis if taken their collagen supplement : Questionnaire (dichotom : Yes vs. No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events (e.g. allergies, gastro-intestinal side effects) related to supplement ingestion</measure>
    <time_frame>Baseline - 12 weeks + 6 month follow-up</time_frame>
    <description>Participants will self-report adverse events during intervention period and at 6 month follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return-to-sport activities</measure>
    <time_frame>Baseline - 12 weeks + 6 month follow-up</time_frame>
    <description>Participants will self-report Return-to-sport activities during intervention period and at 6 month follow-up (dichotom : Yes vs. No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Victorian Institute of Sports Assessment - Patella/Achilles Questionnaire (VISA-P/A) at 12 wks</measure>
    <time_frame>Baseline, 6 and 12 weeks + 6 month follow-up</time_frame>
    <description>Patient reported outcome regarding symptoms, function and the ability to participate in sports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Foot function index - Plantaris questionnaire at 12 wks</measure>
    <time_frame>Baseline, 6 and 12 weeks + 6 month follow-up</time_frame>
    <description>Patient reported outcome regarding symptoms, function and the ability to participate in sports</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tendon Doppler activity using Ultrasonography power Doppler</measure>
    <time_frame>Baseline - 12 weeks</time_frame>
    <description>Using Ultrasonography, we will measure Doppler activity within the affected tendon and use ImageJ for the analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tendon thickness measured using Ultrasonography</measure>
    <time_frame>Baseline - 12 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.</measure>
    <time_frame>Baseline, 6 and 12 weeks + 6 month follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Tendinopathy</condition>
  <arm_group>
    <arm_group_label>Collagen + heavy slow resistance group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily collagen supplementation + heavy slow resistance training three times weekly for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo + heavy slow resistance group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily placebo supplementation + heavy slow resistance training three times weekly for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Hydrolyzed collagen</intervention_name>
    <description>Hydrolyzed collagen supplementation twice daily</description>
    <arm_group_label>Collagen + heavy slow resistance group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heavy slow resistance training</intervention_name>
    <description>Heavy slow resistance training 3 times weekly</description>
    <arm_group_label>Collagen + heavy slow resistance group</arm_group_label>
    <arm_group_label>Placebo + heavy slow resistance group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo supplementation twice daily</description>
    <arm_group_label>Placebo + heavy slow resistance group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elite athletes&#xD;
&#xD;
          -  18-40 years old&#xD;
&#xD;
          -  Exercise related tendon pain on one or both legs&#xD;
&#xD;
          -  Soreness during physical examination of tendon upon palpation&#xD;
&#xD;
          -  Uni- or bilateral tendinopathy symptoms &gt; 3 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous tendon surgery&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Arthritis&#xD;
&#xD;
          -  Corticosteroid injection for tendinopathy within the last 3 months&#xD;
&#xD;
          -  Any form of tendon injection within the last 3 months&#xD;
&#xD;
          -  Smoking&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Couppé, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Sports Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kasper Dideriksen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Team Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kasper Dideriksen, PhD</last_name>
    <phone>+4524251989</phone>
    <email>kasperjuel@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian Couppé, PhD</last_name>
    <phone>+4560660825</phone>
    <email>christian.couppe@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Physical and Occupational Therapy/Institute of Sports Medicine Copenhagen, Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen NV</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Couppé, PhD</last_name>
      <phone>60660825</phone>
      <email>christian.couppe@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Christian Couppé, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kasper Dideriksen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christoffer Brushøj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>January 14, 2021</last_update_submitted>
  <last_update_submitted_qc>January 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Kasper Dideriksen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

